ibandronate sodium
Term · Oncology and biomedicine · MLC-T-ONC-014291
The sodium salt of ibadronic acid, a synthetic nitrogen-containing bisphosphonate. Ibandronic acid inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-related bone pain.
| Identifier | MLC-T-ONC-014291 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ibandronate |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014291",
"term": "ibandronate sodium",
"field": "Oncology and biomedicine",
"definition": "The sodium salt of ibadronic acid, a synthetic nitrogen-containing bisphosphonate. Ibandronic acid inhibits farnesyl pyrophosphate synthase, resulting in a reduction in geranylgeranyl GTPase signaling proteins and apoptosis of osteoclasts. This agent increases bone mineral density, decreases bone remodeling, inhibits osteoclast-mediated bone resorption, and reduces metastases-related and corticosteroid-related bone pain.",
"synonyms": [
"ibandronate"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ibandronate-sodium/"
}
Record 8,888 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.